Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications.
Hindocha S, Campbell D, Ahmed M, Giorgakoudi K, Sharma B, Yousaf N, Molyneaux P, Hunter B, Kalsi H, Cui W, Davidson M, Bhosle J, Minchom A, Locke I, McDonald F, O'Brien M, Popat S, Lee RW. Hindocha S, et al. Front Med (Lausanne). 2021 Nov 1;8:764563. doi: 10.3389/fmed.2021.764563. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34790682 Free PMC article.
Development of a Structured Query Language and Natural Language Processing Algorithm to Identify Lung Nodules in a Cancer Centre.
Hunter B, Reis S, Campbell D, Matharu S, Ratnakumar P, Mercuri L, Hindocha S, Kalsi H, Mayer E, Glampson B, Robinson EJ, Al-Lazikani B, Scerri L, Bloch S, Lee R. Hunter B, et al. Among authors: hindocha s. Front Med (Lausanne). 2021 Nov 4;8:748168. doi: 10.3389/fmed.2021.748168. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34805217 Free PMC article.
A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
Hindocha S, Charlton TG, Linton-Reid K, Hunter B, Chan C, Ahmed M, Robinson EJ, Orton M, Ahmad S, McDonald F, Locke I, Power D, Blackledge M, Lee RW, Aboagye EO. Hindocha S, et al. EBioMedicine. 2022 Mar;77:103911. doi: 10.1016/j.ebiom.2022.103911. Epub 2022 Mar 3. EBioMedicine. 2022. PMID: 35248997 Free PMC article.
Author Correction: Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
Hindocha S, Charlton TG, Linton-Reid K, Hunter B, Chan C, Ahmed M, Greenlay EJ, Orton M, Bunce C, Lunn J, Doran SJ, Ahmad S, McDonald F, Locke I, Power D, Blackledge M, Lee RW, Aboagye EO. Hindocha S, et al. NPJ Precis Oncol. 2022 Nov 23;6(1):87. doi: 10.1038/s41698-022-00332-1. NPJ Precis Oncol. 2022. PMID: 36418522 Free PMC article. No abstract available.
Future Proofing the Clinical Oncology Workforce.
Charlton TG, Hindocha S. Charlton TG, et al. Among authors: hindocha s. Clin Oncol (R Coll Radiol). 2023 May;35(5):314-317. doi: 10.1016/j.clon.2023.02.002. Epub 2023 Feb 8. Clin Oncol (R Coll Radiol). 2023. PMID: 36805130 No abstract available.
74 results